Original Article

You have full text access to this OnlineOpen article

Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain†

A long-term, open-label safety study

  1. Sharon M. Weinstein MD1,‡,*,
  2. John Messina PharmD2,
  3. Fang Xie PhD2

Article first published online: 16 APR 2009

DOI: 10.1002/cncr.24279

Issue

Cancer

Cancer

Volume 115, Issue 11, pages 2571–2579, 1 June 2009

Additional Information

How to Cite

Weinstein, S. M., Messina, J. and Xie, F. (2009), Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain. Cancer, 115: 2571–2579. doi: 10.1002/cncr.24279

Author Information

  1. 1

    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah

  2. 2

    Cephalon, Inc, Frazer, Pennsylvania

  1. ‡

    Fax: (801) 585-0159

*Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Room 2151, Salt Lake City, UT 84112

  1. †

    The authors thank the investigators: Jacob Abraham, MD; Andrea Baxter, MD; Patrick Beatty, MD; Ali Ben-Jacob, MD; Donald Berdeaux, MD; Debra Brandt, MD; Donald Brooks, MD; Daniel Buffington, MD; Jennifer Caskey, MD; Veena Charu, MD; Michael Drass, MD; David Ellison, MD; Orlando Florete, MD; Nashat Gabrail, MD; Gregory Guzley, MD; Martin E. Hale, MD; Youssef Hanna, MD; Mohamed Haq, MD; Jeffrey Hines, MD; Timothy Houden, MD; Haresh Jhangiani, MD; Edward Kaplan, MD; Ronald Kawauchi, MD; Christine Laramee, MD; Gary Lee, MD; Luis A. Meza, MD; Johnny Nacilla, MD; Srinivas Nalamachu, MD; Ravi Patel, MD; John Peppin, DO; Dat Pham, MD; J. Talisman Pomeroy, MD; Russell Portenoy, MD; Richard Rauck, MD; Prabhakara Reddy, MD; Evangeline Reyes, MD; John Roberts, MD; Marc Saltzman, MD; Thalia Segal, MD; Neal Slatkin, MD; Scott Sonnier, MD; Raymond Sorensen, MD; Forrest Swan, MD; Donald Taylor, MD; Howard Terebelo, MD; Rajbala Thakur, MD; John Thropay, MD; James Weick, MD; and Michael Wertheim, MD.

Publication History

  1. Issue published online: 20 MAY 2009
  2. Article first published online: 16 APR 2009
  3. Manuscript Accepted: 17 NOV 2008
  4. Manuscript Revised: 14 NOV 2008
  5. Manuscript Received: 21 AUG 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (182K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Richard Rauck, Lowell Reynolds, Jonathan Geach, Janet Bull, Lisa Stearns, Morris Scherlis, Neha Parikh, Larry Dillaha, Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study, Current Medical Research and Opinion, 2012, 28, 5, 859

    CrossRef

  2. 2
    Mona Darwish, Fang Xie, Pharmacokinetics of Fentanyl Buccal Tablet: A Pooled Analysis and Review, Pain Practice, 2012, 12, 4
    Direct Link:
  3. 3
    Sebastiano Mercadante, Pharmacotherapy for Breakthrough Cancer Pain, Drugs, 2012, 72, 2, 181

    CrossRef

  4. 4
    Augusto Caraceni, Geoffrey Hanks, Stein Kaasa, Michael I Bennett, Cinzia Brunelli, Nathan Cherny, Ola Dale, Franco De Conno, Marie Fallon, Magdi Hanna, Dagny Faksvåg Haugen, Gitte Juhl, Samuel King, Pål Klepstad, Eivor A Laugsand, Marco Maltoni, Sebastiano Mercadante, Maria Nabal, Alessandra Pigni, Lukas Radbruch, Colette Reid, Per Sjogren, Patrick C Stone, Davide Tassinari, Giovambattista Zeppetella, Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC, The Lancet Oncology, 2012, 13, 2, e58

    CrossRef

  5. 5
    G. Zeppetella, Breakthrough Pain in Cancer Patients, Clinical Oncology, 2011, 23, 6, 393

    CrossRef

  6. 6
    Ulrich R. Kleeberg, Marilène Filbet, Giovambattista Zeppetella, Fentanyl Buccal Tablet for Breakthrough Cancer Pain: Why Titrate?, Pain Practice, 2011, 11, 2
    Direct Link:
  7. 7
    Sebastiano Mercadante, Patrizia Ferrera, Claudio Adile, Alessandra Casuccio, Fentanyl Buccal Tablets for Breakthrough Pain in Highly Tolerant Cancer Patients: Preliminary Data on the Proportionality Between Breakthrough Pain Dose and Background Dose, Journal of Pain and Symptom Management, 2011, 42, 3, 464

    CrossRef

  8. 8
    Sebastiano Mercadante, Fentanyl buccal tablets for the treatment of breakthrough pain, Pain Management, 2011, 1, 6, 533

    CrossRef

  9. You have free access to this content9
    John A. Snowden, Sam H. Ahmedzai, John Ashcroft, Shirley D’Sa, Timothy Littlewood, Eric Low, Helen Lucraft, Rhona Maclean, Sylvia Feyler, Guy Pratt, Jennifer M. Bird, Guidelines for supportive care in multiple myeloma 2011, British Journal of Haematology, 2011, 154, 1
    Direct Link:
  10. 10
    E.A. Lux, J. Heine, Häusliche Behandlung von Tumorschmerzpatienten mit patientenkontrollierter Analgesie (PCA), Der Schmerz, 2011, 25, 6, 663

    CrossRef

  11. 11
    Andrew Dickman, Integrated strategies for the successful management of breakthrough cancer pain, Current Opinion in Supportive and Palliative Care, 2011, 5, 1, 8

    CrossRef

  12. 12
    S.R. Nalamachu, A. Narayana, L. Janka, Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients, Current Medical Research and Opinion, 2011, 27, 4, 751

    CrossRef

  13. 13
    Michael A. Ashburn, Kieran A. Slevin, John Messina, Fang Xie, The Efficacy and Safety of Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain, Anesthesia & Analgesia, 2011, 112, 3, 693

    CrossRef

  14. 14
    Constance L. Monitto, Sabine Kost-Byerly, Myron Yaster, Smith's Anesthesia for Infants and Children, 2011,

    CrossRef

  15. 15
    John T. Farrar, John Messina, Fang Xie, Russell K. Portenoy, A Novel 12-Week Study, with Three Randomized, Double-Blind Placebo-Controlled Periods to Evaluate Fentanyl Buccal Tablets for the Relief of Breakthrough Pain in Opioid-Tolerant Patients with Noncancer-Related Chronic Pain, Pain Medicine, 2010, 11, 9
    Direct Link:
  16. 16
    Giovambattista Zeppetella, John Messina, Fang Xie, Neal E. Slatkin, Consistent and Clinically Relevant Effects with Fentanyl Buccal Tablet in the Treatment of Patients Receiving Maintenance Opioid Therapy and Experiencing Cancer-Related Breakthrough Pain, Pain Practice, 2010, 10, 4
    Direct Link:
  17. 17
    Gérard E. Plante, Theodore B. VanItallie, Opioids for cancer pain: the challenge of optimizing treatment, Metabolism, 2010, 59, S47

    CrossRef

  18. 18
    Perry G. Fine, Arvind Narayana, Steven D. Passik, Treatment of Breakthrough Pain with Fentanyl Buccal Tablet in Opioid-Tolerant Patients with Chronic Pain: Appropriate Patient Selection and Management, Pain Medicine, 2010, 11, 7
    Direct Link:
  19. 19
    Lona Louring Christrup, Lena Lundorff, Mads Werner, Novel formulations and routes of administration for opioids in the treatment of breakthrough pain, Therapy, 2009, 6, 5, 695

    CrossRef

View Full Article (HTML) Get PDF (182K)